Global Clinical Diagnostics Market Set for Unprecedented Growth, Projected to Reach USD 126.6 Billion by 2032

The global clinical diagnostics market is on the verge of experiencing unparalleled growth, according to a newly published market analysis report. Projections indicate that the market will reach a remarkable valuation of USD 126.6 billion by 2032, driven by a robust Compound Annual Growth Rate (CAGR) of 5.5% from 2022 to 2032.

By the close of 2022, the market is expected to total approximately USD 74 billion, marking a significant surge fueled by the increasing demand for advanced diagnostic procedures worldwide. This rapid growth underscores the rising importance of accurate and efficient diagnostic tools across diverse medical fields, as healthcare providers increasingly rely on them for timely and precise diagnoses.

The heightened demand for diagnostic solutions is largely attributed to the growing focus on early detection and personalized medicine, with blood tests and other diagnostic procedures taking center stage in modern healthcare. As patients and providers alike emphasize the need for tailored treatment plans, the clinical diagnostics sector is becoming an essential cornerstone of contemporary healthcare, driving innovation and improvements that have the potential to transform patient care globally.

Key drivers behind this exceptional growth include the rising prevalence of chronic diseases, technological advancements in diagnostic tools, and a growing emphasis on preventive healthcare. As healthcare providers prioritize accurate and timely diagnoses, the clinical diagnostics market is positioned to play a pivotal role in shaping the future of healthcare delivery.

As the market continues its expansion, stakeholders across the healthcare ecosystem are poised to benefit from the ongoing innovations and advancements within clinical diagnostics, ultimately enhancing patient outcomes and improving the quality of care worldwide.

Key Highlights of the Report:

  • Global clinical diagnostics market expected to reach USD 126.6 Billion by 2032.
  • Robust Compound Annual Growth Rate (CAGR) of 5.5% projected from 2022 to 2032.
  • Surge fueled by escalating demand for blood tests and other diagnostic procedures.
  • Factors driving growth include technological advancements, expanding healthcare infrastructure, and emphasis on preventive healthcare measures.

As the demand for clinical diagnostics products continues to escalate, stakeholders across the healthcare industry are poised to capitalize on this unprecedented growth opportunity. This surge not only signifies a significant market expansion but also underscores the critical role of diagnostic tools in enhancing patient care and advancing medical outcomes.

Key Takeaways from Clinical Diagnostics Market:

  • North America holds the largest market share with the US being subject to tremendous increase in clinical diagnostics products’ sales coupled with rising incidences of chronic and infectious diseases.
  • The Asia-Pacific is expected to grow at the fastest pace in the clinical diagnostics market. This could be credited to increase in healthcare infrastructure all across India and China.
  • Europe is expected to grow on the similar grounds in the clinical diagnostics market in the forecast period.

Explore the Full Market Scope: Find the Complete Clinical Diagnostics Market Report Here

Competitively Clinical Diagnostics

  • Hoffmann-La Roche Ltd., in March 2021, inked a definitive merger agreement with GenMark Diagnostics Inc. with the objective of helping it to test for a wide spectrum of pathogens through sampling.
  • Ortho Clinical Diagnostics, in September 2021, did announce availability of ISXM (Immediate Spin Crossmatch) under the category of ‘Ortho Vision Max Analyzers’ for helping in detection of incompatibility between donors and recipients in the blood transfusions.
  • TGA (Therapeutic Goods Administration), in January 2022, did grant provisional approval for Nuvaxovid (Covid-19 vaccine by Novavax) for usage in Australia.
  • Mindray, in March 2022, came up with BC-700 Series (a hematology analyzer series helping in erythrosyte sedimentation and blood count rate tests).
  • Qiagen Inc., in May 2022, came up with NeuMoDxHSSV ½ Quant Assay to quantify and differentiate herpes simplex virus type 1 (HSV – 1) DNA and herpes simplex virus type 2 (HSV-2) with the European Commission having approved it.

What does the Report say?

  • The research study is based on test (lipid panel clinical diagnostics, liver panel clinical diagnostics, renal panel clinical diagnostics, complete blood count clinical diagnostics, clinical diagnostics for electrolyte testing, clinical diagnostics for infectious disease testing, and other clinical diagnostics tests), by product (clinical diagnostics instruments, clinical diagnostics reagents, and other clinical diagnostics products), and by end-user (clinical diagnostics for hospital laboratories, clinical diagnostics for diagnostics laboratories, clinical diagnostics for point-of-care testing, and clinical diagnostics for other end-users).
  • Increase in occurrences of blood tests is expected to catalyze the clinical diagnostics market in the forecast period.

Key Companies Profiled:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Siemens AG
  • Hologic Inc.
  • Qiagen NV
  • Hoffmann-La Roche AG
  • Thermo Fischer Scientific
  • Quest Diagnostics Inc.
  • Sysmex Corporation
  • Charles River Laboratories

Key Segments of Clinical Diagnostics Industry Survey:

Clinical Diagnostics Market by Test:

  • Lipid Panel Clinical Diagnostics
  • Liver Panel Clinical Diagnostics
  • Renal Panel Clinical Diagnostics
  • Complete Blood Count Clinical Diagnostics
  • Clinical Diagnostics for Electrolyte Testing
  • Clinical Diagnostics for Infectious Disease Testing
  • Other Clinical Diagnostics Tests

Clinical Diagnostics Market by Product:

  • Clinical Diagnostics Instruments
  • Clinical Diagnostics Reagents
  • Other Clinical Diagnostics Products

Clinical Diagnostics Market by End-User:

  • Clinical Diagnostics for Hospital Laboratories
  • Clinical Diagnostics for Diagnostic Laboratories
  • Clinical Diagnostics for Point-of-Care Testing
  • Clinical Diagnostics for Other End-Users

Clinical Diagnostics Market by Region:

  • North America Clinical Diagnostics Market
  • Latin America Clinical Diagnostics Market
  • Europe Clinical Diagnostics Market
  • Asia Pacific Clinical Diagnostics Market
  • Middle East & Africa (MEA) Clinical Diagnostics Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Blood Glucose Monitoring Devices Market to Reach USD 22.2 Billion by 2034, Driven by Rising Diabetes Prevalence and Aging Population | FMI

The global blood glucose monitoring devices market is poised for significant growth, with an estimated valuation of USD 14.2 billion in 2024. According to recent market analysis, the market is projected to surpass USD 22.2 billion by 2034, reflecting a strong compound annual growth rate (CAGR) over the next decade.

This rapid expansion is primarily fueled by the rising prevalence of diabetes worldwide, coupled with the increasing proportion of the aging population. As the global burden of diabetes continues to rise, the demand for effective, user-friendly blood glucose monitoring solutions is expected to surge.

“Diabetes is a growing global health concern, with millions of people managing the condition every day. Blood glucose monitoring devices have become essential tools for individuals to maintain control over their blood sugar levels,” said FMI. “With an increasingly older population and the rise in diabetes cases, the demand for these devices will continue to grow, driving innovation and advancements in the market.”

Key market trends contributing to this growth include the development of non-invasive monitoring devices, advancements in mobile health (mHealth) technology, and increased awareness of diabetes management. Furthermore, the shift towards home-based diabetes management, particularly in developed markets, has accelerated the adoption of blood glucose monitoring devices.

As the market evolves, manufacturers are focusing on improving accuracy, ease of use, and affordability, ensuring better patient outcomes and increasing access to vital diabetes management tools.

The blood glucose monitoring devices market is expected to continue expanding as the healthcare landscape adapts to the growing global health challenges posed by diabetes and an aging population.

Key Takeaways: Blood Glucose Monitoring Devices Market

  1. The global blood glucose monitoring devices market is projected to grow from USD 14.2 billion in 2024 to USD 22.2 billion by 2034. This growth is primarily driven by the rising prevalence of diabetes and an ageing global population.
  2. In China, the market is expected to benefit from increased product accessibility, heightened consumer awareness, and business expansion. Government initiatives like the “National Diabetes Programme,” supported by the World Diabetes Foundation, aim to improve diabetes treatment and management, further fueling market growth.
  3. In the USA, the increasing obesity rates, which contribute to higher instances of type 2 diabetes, drive the demand for blood glucose monitoring devices. With an estimated 1.5 million new diabetes diagnoses in 2020 alone, the U.S. market is poised for continued growth.
  4. In Germany, the market is influenced by stringent price regulation and reimbursement policies, such as the reimbursement approval for Dexcom’s continuous glucose monitoring system. New product innovations and international research collaborations are expected to further expand the market.
  5. The UK market is poised for growth, driven by increased awareness of blood glucose management and its association with chronic diseases. As understanding of this connection deepens, significant opportunities are expected to arise during the forecast period.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!

Competitive Landscape:

To meet rising consumer demand and broaden their customer base, key industry players are focusing on strategies such as new product launches, securing regulatory approvals, acquisitions, enhancing existing products and technologies, and other initiatives to expand their business portfolios and strengthen their market presence.

Recent Developments:

  • In June 2022, Abbott introduced a new bio-wearable device that continuously monitors both ketone and glucose levels using a single sensor. This system has been granted Breakthrough Device Designation by the U.S. FDA.
  • In November 2021, Intuity Medical launched the POGO Automatic Blood Glucose Monitoring System, the first automatic glucose monitor that lances and collects blood for testing without manual intervention.

Key Companies Profiled:

  • ARKRAY, Inc.
  • Bayer AG; Medtronic plc
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Ascensia Diabetes Care
  • Nipro Diagnostics, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Terumo Medical Corporation
  • Novo Nordisk
  • Ypsomed Holdings
  • Prodigy Diabetes Care, LLC
  • GlySens Incorporated
  • ACON Laboratories
  • Nova Biomedical
  • Medtronic
  • Dexcom, Inc.
  • LifeScan IP Holdings, LLC
  • Senseonics

Key Market Segments Covered in Blood Glucose Monitoring Devices Industry Research:

By Product:

  • Self-monitoring device
  • Continuous blood glucose monitoring devices

By Usage:

  • Non-invasive
  • Invasive

By Modality:

  • Standalone
  • Portable

By Indication:

  • Type 1
  • Type 2
  • Gestational Diabetes

By Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Diagnostic Centres
  • Online Sales

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Bronchodilator Market to Total USD 67.8 Billion by 2034 on the Back of Rising Geriatric Population and Growing Prevalence of Respiratory Diseases

The global bronchodilator market value is predicted to increase from USD 38.2 billion in 2024 to USD 67.8 billion by 2034. Over the forecast period, global bronchodilator sales are projected to rise at a CAGR of about 5.9%.

Several factors are anticipated to spur growth in the bronchodilator industry. These include the rising prevalence of respiratory diseases such as asthma and COPD, the growing geriatric population, and increasing government initiatives and programs.

The rising geriatric population globally is emerging as a key factor driving demand for bronchodilators. As age increases, people become more susceptible to lung problems. According to the journal Clinical Interventions in Ageing, the aging population is significantly impacted by pulmonary illness.

The third most common cause of death in adults 65 and older is chronic lower respiratory tract disease, comprising asthma, emphysema, chronic bronchitis, bronchiectasis, and chronic obstructive pulmonary disease (COPD). Bronchodilators have become essential medication for treating these diseases and relieve their symptoms.

Exposure to air pollution increases the risk of developing non-communicable diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), ischemic heart disease, and stroke. The growing prevalence of these diseases is set to bolster sales of bronchodilators through 2034.

Governments worldwide are also supporting the growth of the global bronchodilator market by increasing awareness among the population through patient education programs. These are the reasons why the market for bronchodilators is expanding.

Key players are focusing on novel product development with enhanced efficacy. They are investing heavily in research and development to develop new medications for respiratory diseases. For instance, Glenmark recently introduced Tavulus for the treatment of COPD in Spain.

Key Takeaways from the Market Study-

  • The global bronchodilator market is expected to total USD 67.8 billion in 2034.
  • By drug class, the phosphodiesterase inhibitor segment is set to thrive at a CAGR of 2%.
  • Based on indication, the asthma segment held a market share of about 2% in 2023.
  • By route of administration, the oral segment is poised to exhibit a CAGR of 4% through 2034.
  • By distribution channel, retail pharmacies accounted for a market share of 4% in 2023.
  • North America dominated the global market with a value share of 5% in 2023.
  • The United States market is set to expand at 1% CAGR through 2034.
  • Demand in India is projected to increase at a CAGR of 2% between 2024 and 2034.

“The rising prevalence of lung diseases such as COPD and asthma is expected to drive demand for bronchodilators during the forecast period. Subsequently, increasing government initiatives to reduce the burden on the healthcare system is set to propel the growth of the bronchodilator industry globally,” says an analyst of Future Market Insights (FMI).

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Landscape

Bronchodilator manufacturers are operating at full capacity to meet the increasing demand globally. They are launching novel products and adopting strategies such as mergers, partnerships, acquisitions, and collaborations to boost their revenue and expand their footprint.

For instance,

  • In May 2020, Glenmark launched a 3-in-1 inhaler therapy for COPD in India with the promise of lowering the likelihood of severe attacks and enhancing lung function.
  • In April 2019, Circassia announced that the FDA had approved Duaklir for the maintenance treatment of chronic obstructive pulmonary disease.

Key Players:

  • Abbott Laboratories
  • AstraZeneca plc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG.
  • Pfizer Inc.
  • SANOFI
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group Plc.
  • Sunovion Pharmaceuticals Inc
  • Aerogen Pharma Ltd
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.

Bronchodilator Market Outlook by Category:

By Drug Class:

  • Sympathomimetic
  • Anticholinergics
  • Phosphodiesterase Inhibitor
  • Combination Drugs
  • Others

By Application:

  • Asthma
  • COPD
  • Others

By Route of Administration:

  • Oral
  • Injection
  • Inhalation

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce
  • Drug Stores

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Nuclear Medicine Equipment Market Poised for Significant Growth, Projected to Reach USD 3.4 Billion by 2032 at a stable CAGR of 4.1%

The global nuclear medicine equipment market is set to experience remarkable growth, with projections indicating an increase from USD 2.3 billion in 2022 to USD 3.4 billion by 2032. This growth reflects a robust compound annual growth rate (CAGR) of 4.1% over the next decade, highlighting the sector’s critical role in advancing healthcare.

Several key factors are driving this positive outlook for the nuclear medicine equipment industry. A notable increase in the prevalence of chronic diseases is at the forefront of this growth. As chronic conditions become more common, the demand for advanced diagnostic and therapeutic tools—including nuclear medicine equipment—continues to rise.

The aging population further propels market expansion. Older adults are more susceptible to age-related ailments, creating a significant need for effective management and treatment solutions that nuclear medicine equipment provides. This demographic trend is expected to persist, contributing to sustained market growth in the coming years.

In addition to these factors, the growing interest in personalized medicine among patients and healthcare professionals is reshaping the landscape of nuclear medicine. This approach tailors treatments to individual patient characteristics, relying on precise diagnostic tools such as nuclear medicine equipment to achieve optimal outcomes.

The increasing adoption of nuclear medicine across various medical fields underscores its vital role in modern healthcare. As the market evolves, stakeholders can anticipate ongoing innovations and advancements that will further enhance the capabilities and applications of nuclear medicine equipment.

Key Takeaways:

  • The nuclear medicine equipment market growth is likely to be hampered by high installation and running expenses, as well as product recalls, over the forecast period.
  • One of the primary reasons projected to drive nuclear medicine equipment market expansion over the forecast period is the rising prevalence of chronic disorders.
  • SPECT segment leads the nuclear medicine equipment market share with the projected CAGR of 4.92% by 2032.
  • Oncology leads the nuclear medicine equipment market with the projected CAGR of 4.3% by 2032.
  • From 2021 to 2032, the academic and research institutes segment is expected to grow at the fastest rate of 6.1 percent. This is attributable to an increase in nuclear medicine research and development activities.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape:

To enhance their nuclear medicine equipment market share, leading players in the worldwide nuclear medical equipment market are focused on new product introductions. Several companies are prioritising new releases, product approvals, and other organic growth techniques like patents and events.

In the nuclear medicine equipment market, acquisitions, partnerships, and collaborations were viewed as inorganic growth strategies. These initiatives have paved the road for market players to develop their business and client base and transform the nuclear medical equipment market picture.

Key Players in the nuclear medicine equipment market include Philips Healthcare, GE Healthcare, Siemens Healthineers AG, Digirad Corporation, Mediso Medical Imaging Systems Ltd, DDD-Diagnostics A/S, Neusoft Medical Systems Co. Ltd., SurgicEye GmbH, and CMR Naviscan Corporation.

With high entry hurdles, advanced technical advances, and significant clinical and nonclinical unmet needs to meet, the nuclear medicine equipment market appears to have a bright future.

Recent Development in the Nuclear Medicine Equipment Market:

Curium purchased IASON, an Austrian radiopharmaceutical company, in June 2021 to expand its diagnostic product portfolio in Europe.

Lantheus, a company that makes diagnostic imaging agents and equipment in the United States, received FDA approval for PYLARIFY injectable in May 2021. The injection is the first commercially available PSMA PET imaging agent for prostate cancer.

Key Segments:

By Product:

  • SPECT
    • Hybrid SPECT
    • Standalone SPECT
  • Hybrid PET
  • Planar Scintigraphy

By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End User:

  • Hospitals
  • Imaging Centers
  • Academic & Research Institutes
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Atrial Appendage Occluder Market Rises among Increasing Thromboembolism and Atrial Fibrillation Cases | FMI

The atrial appendage occluder market size is projected to be valued at USD 983.5 million in 2023 and is expected to rise to USD 8193.0 million by 2033. The sales of atrial appendage occluders are projected to expand at a significant CAGR of 23.6% during the forecast period.

Atrial appendage occluders are medical devices used to close off the left atrial appendage, a small pouch in the heart that is prone to blood clot formation in patients with atrial fibrillation.

The market for atrial appendage occluders is driven by several factors. Firstly, there has been a significant increase in the prevalence of atrial fibrillation globally, primarily due to aging populations and the growing burden of risk factors such as obesity, diabetes, and hypertension. As a result, there is a high demand for effective treatment options to manage this condition and reduce the associated risks.

There is a growing preference for minimally invasive procedures among patients and healthcare providers. Atrial appendage occluders offer a less invasive alternative to open-heart surgery for the closure of the left atrial appendage.

Advancements in technology and product innovation have enhanced the safety and efficacy of atrial appendage occluders. Further, manufacturers are developing next-generation devices with improved design features, such as better sealing mechanisms, ease of implantation, and enhanced long-term outcomes.

Looking ahead, the atrial appendage occluder market is expected to continue its growth trajectory. Moreover, the increasing prevalence of atrial fibrillation, the demand for minimally invasive treatments, and ongoing advancements in device technology are estimated to drive the market’s expansion.

Key Takeaways:

  • The endocardial segment is expected to dominate the global atrial appendage occluder market, accounting for a market share of 87.20%. This segment is preferred due to its safety and effectiveness, supported by positive results from clinical studies. It is anticipated to have a low complication rate compared to the epicardial segment, driving its growth.
  • The epicardial segment is forecasted to hold a market share of 15%.
  • The hospital segment is projected to be the most dominant contributing to 63.20% of the global atrial appendage occluder market. The increasing number of hospitals and improved infrastructure are driving the demand for these devices.
  • North America is expected to dominate the atrial appendage occluder market, with a market share of 39.8%. The region’s large geriatric population and the high number of stroke-related deaths contribute to the increased demand for atrial appendage occluders in this market.
  • The demand for atrial appendage occluders is likely to rise with over 6 million people in Europe living with arrhythmia, and the number is expected to double in the next 50 years The European race has a high incidence of atrial fibrillation, and sedentary lifestyles in developed nations contribute to cardiovascular problems. Europe held a market share of 27.3% in the atrial occluder market in 2022.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Recent Developments:

  • In June 2022, AtriCure, Inc., a pioneer in surgical treatments and therapies for atrial fibrillation, left atrial appendage (LAA) control, and post-operative pain management, announced that the first patient in the HEAL-ISTTM study has been treated (NCT 05280093). Drs. Mark LaMeir and Carlo de Asmundis treated the first patient at University Hospital Brussels.
  • In May 2022, B. Braun Interventional Systems Inc. secured an exclusive distribution deal with Occlutech (BIS). With the backing of the worldwide Occlutech team, BIS is going to begin US commercialization initiatives for Occlutech’s Flex II ASD Occluder.

Key Companies Profiled:

Appriva Medical Inc.; Boston Scientific; Abbott; SentreHEART Inc; pfm medical ag.; Occlutech; W. L. Gore & Associates; Coherex Medical, Inc.; Cardia, Inc.; AtriCure, Inc.

Key Segments Covered in the Atrial Appendage Occluder Market Report:

By Type of indication:

  • Non-valvular Atrial Fibrillation

The Procedure of Positioning of the Device:

  • Endocardial
  • Epicardial

By End-user:

  • Hospitals
  • Clinics

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)


About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Glucose Monitoring Device Market Value to Reach a Staggering USD 44.6 Billion by 2034 Amid High Diabetes Prevalence Globally

As per Future Market Insights’ latest analysis, the global glucose monitoring device market value is estimated to reach USD 16.2 billion in 2024. Global sales are projected to soar at 10.6% CAGR throughout the forecast period, totaling a valuation of USD 44.6 billion by 2034.

Demand will remain particularly high for continuous blood monitoring devices owing to their multiple advantages. Future Market Insights analysts estimated a robust CAGR of 14.7% for the target segment.

Multiple factors are providing impetus for the growth of the glucose monitoring device market. These include high prevalence of diabetes, growing health awareness, increasing popularity of home healthcare, and surging need for early diabetes management.

Annually, millions of people are affected by diabetes. For instance, according to the International Diabetes Federation, around 537 million adults are living with diabetes. This, in turn, is creating a need for constant monitoring of blood sugar levels, which will propel glucose monitoring device demand.

Glucose monitoring devices are witnessing strong demand as they provide insights into blood glucose levels with or without the need for blood. These devices have become key tools in diabetes management globally.

Glucose monitoring devices have proven efficacy in prolonging and enhancing the lives of patients with cardiovascular conditions. They offer precise monitoring, timely intervention, and life-saving therapies, thereby reducing morbidity and mortality rates associated with diseases like diabetes.

Initially, self-monitoring devices were available at a cheaper price, which required the finger prick process. But later on, continuous monitoring devices (CGM) were launched as there was a high need for minimally invasive techniques.

Growing adoption of continuous monitoring devices will benefit the market. The approach to non-invasive solutions combined with the simplicity, accuracy, and connectivity provided by CGM devices makes them a good choice for people looking to improve their blood sugar readings.

Key Takeaways from the Market Study:

  • The global glucose monitoring device industry is estimated to total USD 44.6 billion by 2034.
  • By product, the CGM segment is set to grow at a higher CAGR of 7% through 2034.
  • Based on indication, the diabetes II category will account for a market share of around 4% in 2024.
  • By end-users, the hospital segment accounted for a noteworthy share of 2% in 2023.
  • The United States market value is poised to reach USD 4,910.2 million in 2024
  • Demand across India is anticipated to surge at 6% CAGR through 2034.

“Non-invasive nature of continuous glucose monitoring (CGM) and its comfort and accuracy are fueling the adoption of these devices. Similarly, ongoing advances in CGM devices, such as integration of AI technology and developed sensor technology, will benefit the market,” says a lead analyst of Future Market Insights.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Who is Winning?

Diversifying their product offerings through advances in device technology is a core strategy employed by leading manufacturers in the market. Several notable product launches have been undertaken by key players to maintain their competitive edge.

Recent Developments:

  • In May 2022, Abbott received the U.S. Food and Drug Administration (FDA) approval of its latest FreeStyle Libre 3 system for individuals aged four and above who have diabetes.
  • In October 2022, Ascensia Diabetes Care, a global company specializing in diabetes care, successfully launched the advanced Eversense® E3 CGM System in Europe.

Key Players in the Glucose Monitoring Device Market:

  • Abbott Laboratories
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Medtronic
  • LifeScan IP Holdings, LLC
  • Ascensia Diabetes Care Holdings AG.
  • ARKRAY, Inc.
  • ACON Laboratories, Inc.
  • NIPRO
  • Nova Biomedical
  • Ypsomed
  • Prodigy Diabetes Care, LLC.
  • ForaCare, Inc.
  • Trividia Health, Inc.
  • AgaMatrix
  • Beurer GmbH
  • All Medicus Co., Ltd.

Global Glucose Monitoring Device Market Segmentation:

By Product:

  • Continuous Monitoring Devices
    • Monitors
    • Sensors
    • Transmitters
  • Self-monitoring Devices

By Indication:

  • Diabetes Type I
  • Diabetes Type II
  • Gestational Diabetes

By End-user:

  • Hospitals
  • Clinics
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pessary Market Poised for Significant Growth, Projected to Reach USD 831.3 Million by 2032 with a CAGR of 10.2%

The global pessary market is set to experience remarkable expansion, driven by increased awareness of incontinence and pelvic floor disorders. According to a recent report by Future Market Insights, the market size, valued at approximately USD 316 million in 2022, is projected to grow at a robust compound annual growth rate (CAGR) of 10.2% over the next decade. By 2032, the market is anticipated to reach an impressive USD 831.3 million.

Pessaries, one of the oldest and most reliable medical devices, continue to play a crucial role in managing stress urinary incontinence (SUI) and pelvic organ prolapse (POP). These devices, typically made from silicone or rubber, are inserted into the vagina to provide essential support to the pelvic floor muscles, effectively alleviating symptoms associated with incontinence and prolapse.

Healthcare providers prescribe pessaries based on factors such as the severity of SUI, the presence of prolapse, and the patient’s level of sexual activity to ensure both comfort and efficacy. Advances in materials and design have led to more personalized and effective treatment options, allowing pessaries to meet the evolving needs of patients more effectively.

The rising prevalence of urinary incontinence and pelvic floor disorders, coupled with an aging population, is significantly boosting demand for pessaries. Additionally, increased patient education and awareness initiatives are expected to further drive market growth in the coming years.

Manufacturers are prioritizing innovation and product development to address unmet patient needs and improve treatment outcomes. Strategic collaborations between healthcare organizations and industry players are also anticipated to accelerate advancements in pessary technology, enhancing patient care and treatment effectiveness.

As the global pessary market continues to grow, it underscores the importance of ongoing advancements and innovations in medical technology to support patient well-being and quality of life.

Key Takeaways:

  • The global Pessary Industry is expected to grow significantly in the coming years, driven by the increasing prevalence of pelvic organ prolapse and urinary incontinence, as well as the growing awareness of pessaries as a non-surgical treatment option for these conditions.
  • North America is expected to remain the largest market for pessaries throughout the forecast period, followed by Europe and Asia Pacific.
  • Ring pessaries are expected to be the most popular type of pessary during the forecast period.
  • Silicone pessaries are expected to be the most popular material for pessaries during the forecast period.
  • Hospital pharmacies are expected to be the most popular distribution channel for pessaries during the forecast period.

Pessary Market Trends: Discover the Full Details in Our Extensive Report!

Key Companies Covered:

  • MedGyn Products, Inc.
  • Cooper Surgical Inc.
  • Personal Medical Corp.
  • Panpac Medical Corp
  • Smiths Medical
  • Thomas Medical
  • Artisan Medical
  • Bioteque America, Inc.
  • Integra LifeSciences Corporation
  • Dr. Arabin GmbH & Co.
  • Medgyn Products, Inc.
  • Wallach Surgical Devices

Some of the recent developments in the Pessary Industry are mentioned below:

  • In February 2022, Cooper Companies agreed to purchase Cook Medical’s Reproductive Health division, which manufactures noninvasive fertility, obstetrics, and gynecology devices. Cooper will pay USD 875 million in total, with USD 675 million paid at closing and the remaining USD 200 million paid in four USD 50 million annual installments.
  • In February 2022, Theramex, a global pharmaceutical company specializing in women’s health expanded its initial collaboration with Endoceutics to commercialize Intrarosa in Australia. Intrarosa is the first and only DHEA treatment that has been approved for postmenopausal women suffering from moderate to severe vulvovaginal atrophy.
  • In August 2021, Liv Labs developed a reusable female comfort pessary that does not require a doctor’s prescription. Patients suffering from incontinence are currently fitted for pessaries, which must be worn for six months before being removed.
  • The Liv Labs pessary is soft, smooth, and squishy, making insertion and removal easier. It is made of medical-grade silicone. Women can use it whenever they want, whether it is all day or just for a quick trip to the gym.

Market Segments Covered in Pessary Industry Analysis:

By Type:

  • Gellhorn
  • Ring
  • Donut
  • Other Types

By End-Use:

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Medical Polyetheretherketone Market Set for Substantial Growth to Reach USD 1158.26 Million by 2032 | FMI

The global medical polyetheretherketone market is on track for significant growth, according to the latest industry analysis. Valued at USD 572.54 million in 2022, the market is projected to reach an impressive USD 1158.26 Million by 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.3%. This growth is primarily driven by increasing demand for PEEK in the medical industry, along with advancements in manufacturing technology.

PEEK, a high-performance thermoplastic polymer known for its outstanding properties, including high temperature resistance, biocompatibility, and durability, is rapidly gaining traction across the medical sector. Its superior mechanical strength and radiolucency have made it the material of choice for a wide range of medical devices, implants, and equipment, which, in turn, enhances overall performance and improves patient outcomes.

“The growing adoption of PEEK in various medical applications is a direct result of its unique ability to withstand sterilization processes, maintain structural integrity under stress, and integrate seamlessly with human tissue,” said a the market research team. “These characteristics make it an ideal material for spinal implants, orthopedic devices, and dental applications, which are crucial in improving the quality of care.”

Technological advancements in PEEK manufacturing are accelerating the market’s expansion. Increased investments in research and development have spurred innovations in PEEK-based medical solutions, driving its adoption across both existing and emerging medical applications. These advancements are expected to enhance patient care and deliver greater operational efficiencies for healthcare providers globally.

The increasing focus on minimally invasive surgical procedures, supported by favorable regulatory policies, is further fueling the demand for high-performance materials like PEEK in the healthcare sector. Additionally, the Asia-Pacific region is expected to experience a surge in revenue, with a projected growth rate of 8.7% throughout the forecast period. Notably, cardiovascular applications are leading the market in the region, with a medical PEEK market value of USD 36.17 million in 2021, driven by the rising incidence of sedentary lifestyles in countries like China and India.

As the healthcare industry continues to evolve, the demand for advanced materials such as PEEK is set to rise, offering a promising outlook for the global market over the next decade.

Key Takeaways from Market Study:

  • In 2021, the spine implantation segment led the medical polyetheretherketone market and contributed for more than 30.0% of global revenue.
  • North America held the biggest medical polyetheretherketone market share in 2021, at over 40 percent, and is anticipated to experience substantial increase throughout the forecast period.
  • In Canada, sales of medical polyetheretherketone are anticipated to expand at a CAGR of around 7% during the coming year. Both the commercial and public sectors are making substantial investments in Canada’s healthcare industry, which is fuelling research and development.
  • There are currently 54 million Americans over the age of 65, and this number is predicted to rise to 74 million by 2030. The elderly population, which requires the most comprehensive care, is growing even more fast. The region’s substantial elderly population is also driving growth in the medical polyetheretherketone industry.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Competitive Landscape:

Due to a few regional players, the global demand for medical polyetheretherketone is consolidated. Important participants include Panjin Zhongrun High-Performance Polymers Co. Ltd., Victrex Plc., Jrlon Inc., and Quadrant EPP Surlon India Ltd.

Increasing overall applicability in a range of areas, such as medical, aerospace, and automotive, has led to the expansion of the industrial service provider market and thus also changing the medical polyetheretherketone market outlook. Prototype & Plastic Mold Co. Inc., Parkway Products Inc., A. Schulman AG, and Stern Sectors Inc. are among the key service providers that use the product for injection moulding and other uses in a variety of industries.

Numerous industries, including as healthcare, aerospace, electronics, packaging, and autos, are anticipated to gain from the expanding medical polyetheretherketone market. Medical industries are patenting polyetheretherketone-based end-use innovations in order to acquire a competitive advantage over rivals.

Medical Polyetheretherketone Market by Segmentation:

By Application:

  • Trauma Fixation
  • Cardiovascular
  • Orthopaedic
    • Spine Implantation
    • Knee & Hip Implantation
  • Dental Implants & Fixtures
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

According to FMI Sugarcane Packaging Market Size, Forecast, Analysis and Share Surpass USD 889.0 Million | 2033, At 13.3% CAGR

Sugarcane packaging is a sustainable and eco-friendly alternative to traditional petroleum-based plastics. The Sugarcane packaging market is projected to reach USD 255.0 Million by 2023 and USD 889.0 Million by 2033, expanding at a CAGR of 13.3% during the forecast period.

Sugarcane packaging is biodegradable, compostable, and recyclable, making it an environment-friendly option.

Sugarcane fibers or sugarcane-derived bioplastics are used to create sugarcane packaging. The biodegradability of sugarcane packaging is one of its main features.

Unlock Comprehensive Insights—Read the Full Report Today!

Governments and organizations throughout the world are enacting legislation and measures to limit plastic waste, recognizing the benefits of sugarcane packaging.

The sugarcane packaging market is primarily used in the food and beverage industry, particularly for packaged food and beverages.

The convenience of packaged food and beverages has become crucial with the rise of e-commerce and online food delivery services.

Many companies are entering the sugarcane packaging market due to the benefits of cost efficiency, increased company brand appeal, and reduced carbon footprint.

Key Takeaways from the Sugarcane Packaging Market:

  • Tableware made from sugarcane bagasse, the fibrous residue remaining after juice extraction, is gaining popularity due to its eco-friendliness and durability. The sugarcane tableware market held a market share of 77.9% in 2022 due to the increasing demand for sustainable and eco-friendly products.
  • The food sector recorded a 68.9% market share in 2022, as it is highly incorporated in food packaging, food service disposables, and beverage packaging. Sugarcane-based packaging is durable, insulating, and resilient to heat and moisture, making it suitable for fast-food restaurants, coffee shops, and other food service operations.
  • Europe is a leading market with a market share of 29.9% in 2022 due to the increasing need for sustainable and eco-friendly packaging options. The food and beverage industry is the important end-user of sugarcane packaging in Europe, with high demand for packaging solutions for fruits and vegetables, baked goods, and ready-to-eat meals.
  • The United States is a lucrative market in North America with a market share of 13.2% in 2022 due to favorable policies encouraging the use of sustainable alternatives such as sugarcane-based packaging. Big corporations, including Coca-Cola and PepsiCo, have pledged to use sustainable packaging options, projected to enhance demand for sugarcane packaging in the country.
  • China is set to be a lucrative market for sugarcane-based packaging market recording a CAGR of 8.4% in 2023 due to the substantial corn sector that provides a low-cost source of raw materials for the manufacture of sugarcane-based packaging solutions.
  • India is also a prominent player in the sugarcane packaging business with a transforming growth rate of 9.3%, as it is one of the world’s top producers of sugarcane. The country’s demand for sustainable packaging solutions has grown in recent years, owing to rising environmental concerns and awareness among consumers and businesses.

Competitive Landscape

The market is characterized by intense competition, with players focusing on innovation and product differentiation to gain a competitive edge. Manufacturers are investing in research and development to create new and improved sugarcane-based packaging products with enhanced properties such as increased strength, durability, and heat resistance.

Market players are focusing on developing customized packaging solutions for specific applications, such as food packaging, to cater to the specific needs of their customers.

Key Players

Amcor Ltd.; Constantia Flexibles Group GmbH; Berry Global Group, Inc.; Huhtamäki Oyj; Sonoco Products Company; Bemis Company, Inc.; Sealed Air Corporation; AR Packaging Group AB; Mondi Group; DS Smith Plc; CCL Industries Inc.

Key Segments Covered in the Sugarcane Packaging Market Report

By Product Type:

  • Pouches
  • Bags
  • Boxes
  • Tableware

By End-Use:

  • Food
  • Personal Care and Cosmetics
  • Pharmaceuticals
  • Retail
  • Textile

By Sales Channel:

  • Online
  • Offline

By Material:

  • Bagasse-based
  • Sugarcane-based

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Oceania Digital Textile Printer Market is Predicted to Reach USD 150.0 Million by 2033 at 4.3% CAGR: Future Market Insights, Inc.

Growth in the Oceania digital textile printer market is anticipated to surge between 2023 and 2033 at a CAGR of 4.3%. By 2033, its value is projected to be over USD 150 million. By 2023, the market is likely to surpass a valuation of about USD 98.4 million.

According to Future Market Insights (FMI), it is anticipated that the growing e-commerce distribution sphere would increase demand for digital textile printing in Oceania. E-commerce has made it simple for small and medium-sized textile producers to connect with a broad clientele.

E-commerce distribution has particularly benefitted those in off-the-grid or underserved regions. On-demand printing has becomes more popular as a result, and digital textile printing technologies are meeting this need.

Explore In-Depth Analysis—Click Here to Access the Report!

The demand for customization and personalization in the textile business has expanded as a result of e-commerce. This is largely due to the increased options being made available to users as a result of the capacity and simplicity of the online interface.

Consumers today want specialized and customized items, which can be produced using digital textile printing techniques that provide design and production flexibility.

The demand for sustainable textiles is also being fueled by e-commerce sites as consumers become more aware of how their purchases affect the environment.

The use of less water and reduced usage of chemicals and energy has become a norm in the industry now. This makes digital textile printing highly environment-friendly when compared to conventional textile printing techniques.

Rising demand for versatile and affordable printing options has been rising due to the stiff competition in this market. This has incentivized small and medium-sized businesses to adopt digital textile printing technology at an accelerated pace. This trend is expected to continue, pushing market growth over the forecast period.

Key Takeaways from Oceania Digital Textile Printers Market Study

  • The Oceania digital textile printer industry is anticipated to reach a valuation of USD 98.4 million by the end of the year 2023.
  • The market is expected to reach a total size of USD 150 million by the end of the forecast period 2023 to 2033.
  • The CAGR for the market during 2023 to 2033 is projected to be at 3%.
  • Clothing & Apparels End Use segment is anticipated to offer an impressive absolute dollar opportunity of USD 25.4 million between 2023 and 2033.
  • Australia is anticipated to be the largest market for digital textile printers across Oceania accounting for a total market valuation of USD 71.6 million in 2023.

“Oceania is experiencing a rapid expansion of digital textile printing due to the region’s growing need for affordable, on-demand textile printing. The use of automation, eco-friendly inks, and direct-to-fabric printing technology has made it possible to print textiles of excellent quality and at a reasonable price. The need for digital textile printing is also increasing as a result of expanding e-commerce distribution options. This is expected to provide small and medium-sized textile manufacturers with access to a larger consumer base and satisfy the increased demand for customization and personalisation.” – says Ismail Sutaria, Principal consultant at Future Market Insights

Competitive Landscape: Digital Textile Printing Market Landscape

The digital textile printing market in Oceania is characterized by key players adopting numerous strategies to remain competitive. While consolidation is a major strategy, the market is also rife with other moves like acquisitions, mergers and product innovations.

HP Inc., Brother International Corporation, Seiko Epson Corporation, Konica Minolta, Inc., Colorjet Group, The M&R Companies, Mimaki Engineering Co., Ltd., Aeoon Technologies GmbH, HGS Machines, Ricoh Company, Ltd, Electronics for Imaging, Inc., Kornit Digital, and others are prominent players in the digital textile printing market. the digital textile printing market is fragmented and the Tier 1 players in the market hold 20-25% share in the Oceania digital textile printer industry.

For instance,

  • In October 2021, Kornit Digital announced a new partnership with Amazon, which will allow Amazon sellers to access Kornit’s digital textile printing technology to create and sell customized printed apparel.

Oceania Digital Textile Printer Market by Category

By Printer Type:

  • Direct to Garment (DTG) Printer
  • Direct to Fabric (DTF) Printer

By Substrate:

  • Cotton
  • Silk
  • Rayon
  • Linen
  • Polyester
  • Polyamide
  • Wool
  • Other Substrates

By Ink Type:

  • Reactive
  • Acid
  • Disperse
  • Pigment

By Printer Type (Size):

  • Industrial Printer
  • Desktop Printer

By Sales Channel:

  • Manufacturers (Direct Sales)
  • Distributors/ Suppliers
  • Retail
  • E-Commerce

By End Use:

  • Clothing & Apparels
    • T-shirts
    • Pants
    • Leggings
    • Caps
    • Sweatshirts
    • Hoodies
    • Shorts
    • Golf shirts
    • Others (Jackets, Tie, etc.)
  • Household
    • Bed Linens
    • Carpets & Curtains
    • Others (Napkins, Towel, etc.)
  • Technical Textiles
  • Others (Flags & Banners)

By Country:

  • Australia
  • New Zealand
  • Papua New Guinea
  • Fiji

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube